XML 68 R50.htm IDEA: XBRL DOCUMENT
v3.25.1

Note 21 - Reportable Segments (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Notes Tables |
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] |
Year Ended December 31, 2024 |  | e-Commerce Operations |  |  | Healthcare Operations |  |  | Eliminations |  |  | Total |
e-Commerce revenue |  | $ | 13,791 |  |  | $ | — |  |  | $ | — |  |  | $ | 13,791 |
Pharmacy prescription and other revenue, net of PBM fees |  |  | — |  |  |  | 41,308 |  |  |  | — |  |  |  | 41,308 |
Pharmacy 340B contract revenue |  |  | — |  |  |  | 10,384 |  |  |  | — |  |  |  | 10,384 |
Revenues, net |  |  | 13,791 |  |  |  | 51,692 |  |  |  | — |  |  |  | 65,483 |
Expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of revenue |  |  | 10,356 |  |  |  | 38,898 |  |  |  | — |  |  |  | 49,254 |
Selling, general and administrative |  |  | 4,134 |  |  |  | 3,726 |  |  |  | — |  |  |  | 7,860 |
Salaries, wages and payroll taxes |  |  | 2,372 |  |  |  | 9,069 |  |  |  | — |  |  |  | 11,441 |
Impairment loss |  |  | — |  |  |  | 13,653 |  |  |  | — |  |  |  | 13,653 |
Professional fees |  |  | 2,900 |  |  |  | 1,741 |  |  |  | (240 | ) |  |  | 4,401 |
Depreciation and amortization |  |  | 539 |  |  |  | 1,959 |  |  |  | — |  |  |  | 2,498 |
Total expenses |  |  | 20,301 |  |  |  | 69,046 |  |  |  | (240 | ) |  |  | 89,107 |
Operating loss |  |  | (6,510 | ) |  |  | (17,354 | ) |  |  | 240 |  |  |  | (23,624 | )
Interest expense |  |  | 13 |  |  |  | 68 |  |  |  | — |  |  |  | 81 |
Other (income) expense |  |  | (647 | ) |  |  | (244 | ) |  |  | 240 |  |  |  | (651 | )
Loss before income taxes |  |  | (5,876 | ) |  |  | (17,178 | ) |  |  | — |  |  |  | (23,054 | )
Income taxes |  |  | (71 | ) |  |  | — |  |  |  | — |  |  |  | (71 | )
Net loss |  | $ | (5,947 | ) |  | $ | (17,178 | ) |  | $ | — |  |  | $ | (23,125 | )
Year Ended December 31, 2023 |  | e-Commerce Operations |  |  | Healthcare Operations |  |  | Eliminations |  |  | Total |
e-Commerce revenue |  | $ | 10,977 |  |  | $ | — |  |  | $ | — |  |  | $ | 10,977 |
Pharmacy prescription and other revenue, net of PBM fees |  |  | — |  |  |  | 21,412 |  |  |  | — |  |  |  | 21,412 |
Pharmacy 340B contract revenue |  |  | — |  |  |  | 5,367 |  |  |  | — |  |  |  | 5,367 |
Revenues, net |  |  | 10,977 |  |  |  | 26,779 |  |  |  | — |  |  |  | 37,756 |
Expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of revenue |  |  | 8,122 |  |  |  | 18,323 |  |  |  | — |  |  |  | 26,445 |
Selling, general and administrative |  |  | 6,633 |  |  |  | 3,277 |  |  |  | — |  |  |  | 9,910 |
Salaries, wages and payroll taxes |  |  | 2,670 |  |  |  | 3,973 |  |  |  | — |  |  |  | 6,643 |
Impairment loss |  |  | — |  |  |  | 13,895 |  |  |  | — |  |  |  | 13,895 |
Professional fees |  |  | 1,595 |  |  |  | 506 |  |  |  | (120 | ) |  |  | 1,981 |
Depreciation and amortization |  |  | 647 |  |  |  | 1,463 |  |  |  | — |  |  |  | 2,110 |
Total expenses |  |  | 19,667 |  |  |  | 41,437 |  |  |  | (120 | ) |  |  | 60,984 |
Operating loss |  |  | (8,690 | ) |  |  | (14,658 | ) |  |  | 120 |  |  |  | (23,228 | )
Interest expense |  |  | 25 |  |  |  | 54 |  |  |  | — |  |  |  | 79 |
Other (income) expense |  |  | (1,072 | ) |  |  | (64 | ) |  |  | 120 |  |  |  | (1,016 | )
Loss before income taxes |  |  | (7,643 | ) |  |  | (14,648 | ) |  |  | — |  |  |  | (22,291 | )
Income taxes |  |  | (28 | ) |  |  | — |  |  |  | — |  |  |  | (28 | )
Net loss |  | $ | (7,671 | ) |  | $ | (14,648 | ) |  | $ | — |  |  | $ | (22,319 | )
Reconciliation of Assets from Segment to Consolidated [Table Text Block] |
|  | e-Commerce Operations |  |  | Healthcare Operations |  |  | Eliminations |  |  | Total |
Total assets as of December 31, 2024 |  | $ | 19,044 |  |  | $ | 17,434 |  |  | $ | — |  |  | $ | 36,478 |
Total assets as of December 31, 2023 |  | $ | 40,764 |  |  | $ | 40,384 |  |  | $ | (16,679 | ) |  | $ | 64,469 |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration